Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fátima Lasala

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Frontiers in Cellular and Infection Microbiology|October 9, 2023
The role of DC-SIGN as a trans-receptor in infection by MERS-CoVNuria Labiod, Joanna Luczkowiak, María M Tapia, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in transFátima Lasala, Eva Arce, Joaquín R Otero, et al.
Structure (London, England : 1993)|October 2, 2004
Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activityLaura G Barrientos, Fátima Lasala, Rafael Delgado, et al.
Protein Engineering, Design & Selection : PEDS|October 3, 2006
Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibitionLaura G Barrientos, Elena Matei, Fátima Lasala, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 25, 2021
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19Maria Dolores Folgueira, Joanna Luczkowiak, Fátima Lasala, et al.
Journal of Virology|June 7, 2002
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in transCarmen P Alvarez, Fátima Lasala, Jaime Carrillo, et al.
ACS Applied Materials & Interfaces|February 5, 2025
Glycan-Silica Nanoparticles as Effective Inhibitors for Blocking Virus InfectionCarmen Pérez-Alonso, Fátima Lasala, Laura Rodríguez-Pérez, et al.
Journal of Clinical Microbiology|March 7, 2002
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosisDarío García de Viedma, Maria del Sol Díaz Infantes, Fátima Lasala, et al.
The Journal of Infectious Diseases|August 3, 2022
Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernJoanna Luczkowiak, Pauline Radreau, Ludovic Nguyen, et al.
AIDS (London, England)|November 25, 2010
TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptideElena Lorente, Susana Infantes, Eilon Barnea, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Cellular and Infection Microbiology|October 9, 2023
The role of DC-SIGN as a trans-receptor in infection by MERS-CoVNuria Labiod, Joanna Luczkowiak, María M Tapia, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in transFátima Lasala, Eva Arce, Joaquín R Otero, et al.
Structure (London, England : 1993)|October 2, 2004
Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activityLaura G Barrientos, Fátima Lasala, Rafael Delgado, et al.
Protein Engineering, Design & Selection : PEDS|October 3, 2006
Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibitionLaura G Barrientos, Elena Matei, Fátima Lasala, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 25, 2021
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19Maria Dolores Folgueira, Joanna Luczkowiak, Fátima Lasala, et al.
Journal of Virology|June 7, 2002
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in transCarmen P Alvarez, Fátima Lasala, Jaime Carrillo, et al.
ACS Applied Materials & Interfaces|February 5, 2025
Glycan-Silica Nanoparticles as Effective Inhibitors for Blocking Virus InfectionCarmen Pérez-Alonso, Fátima Lasala, Laura Rodríguez-Pérez, et al.
Journal of Clinical Microbiology|March 7, 2002
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosisDarío García de Viedma, Maria del Sol Díaz Infantes, Fátima Lasala, et al.
The Journal of Infectious Diseases|August 3, 2022
Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernJoanna Luczkowiak, Pauline Radreau, Ludovic Nguyen, et al.
AIDS (London, England)|November 25, 2010
TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptideElena Lorente, Susana Infantes, Eilon Barnea, et al.
Pageof 4